What Does the Research Say About the Cortisol Rhythm?
Cortisol is the primary glucocorticoid in humans, secreted by the adrenal cortex under hypothalamic-pituitary-adrenal (HPA) axis control. This page summarises what published research reports about its circadian and ultra
Cortisol (hydrocortisone; 11β,17α,21-trihydroxypregn-4-ene-3,20-dione; CAS 50-23-7; molecular formula C21H30O5; molecular weight 362.46 g/mol) is the principal glucocorticoid secreted by the zona fasciculata of the adrenal cortex in humans. It is a steroid hormone of the pregnane class, synthesised from cholesterol via the Δ5 pathway through pregnenolone, progesterone, 17α-hydroxyprogesterone and 11-deoxycortisol, and it circulates largely bound to corticosteroid-binding globulin (CBG) with a smaller free fraction. The research literature on cortisol timing centres on the hypothalamic-pituitary-adrenal (HPA) axis, a neuroendocrine system whose output is organised into circadian and ultradian rhythms and which terminates in glucocorticoid receptor (GR, NR3C1) and mineralocorticoid receptor (MR, NR3C2) signalling in target tissues [2].
The HPA axis maintains homeostasis by regulating stress hormone secretion through tightly controlled circadian and ultradian rhythms, and the mechanisms of ultradian pulsatility have been clarified chiefly in rodent studies and mathematical models rather than in human tissue [2]. Clinical interest in the rhythm is driven in part by metabolic endpoints: chronic sleep loss is highly prevalent, affecting roughly 1 in 3 adults in the United States, and it causes stress that induces insulin resistance and contributes to obesity and type 2 diabetes [1]. Sleep loss increases the stress hormone cortisol in the evening and decreases daytime testosterone, and controlled laboratory protocols have been designed specifically to examine the impact of timed cortisol release, or differently timed cortisol rhythms, on insulin resistance in both men and women undergoing sleep restriction [1].
Research Studies
Cortisol rhythm and insulin resistance in sleep-restricted adults
A registered clinical study examines the impact of timed cortisol release, or differently timed cortisol rhythms, on insulin resistance in both men and women undergoing sleep restriction [1]. The rationale given is that chronic sleep loss causes stress which induces insulin resistance and leads to obesity and type 2 diabetes, and that many factors contribute to sleep loss, including shift work, environmental disturbances, sleep and circadian disorders, and comorbid medical and mental health conditions [1]. The protocol measures evening cortisol and daytime testosterone in a controlled laboratory environment [1]. This is a human study design; the findings are not yet reported in the evidence available here.
Cortisol rhythm and the HPA axis in human and model systems
The HPA axis is described as a vital neuroendocrine system that maintains homeostasis by regulating stress hormone secretion through tightly controlled circadian and ultradian rhythms [2]. Rodent studies and mathematical models have clarified the mechanisms of ultradian pulsatility, while quantitative characterisation in humans remains an active area [2]. This distinction matters for interpretation: pulsatility mechanisms established in rodents should not be assumed to transfer directly to human physiology without human data.
Cortisol excess and bone in pregnant and postpartum patients
Cushing syndrome (CS) is a major cause of secondary osteoporosis, and postpartum fractures associated with CS have occasionally been reported [3]. Fractures occurring during pregnancy in patients with CS are exceptionally rare, and several cases of adrenal CS that became apparent or worsened during pregnancy have been described [3]. This literature concerns clinical populations with diagnosed cortisol excess and is not a study of cortisol rhythm in healthy adults.
Epitalon and telomerase in aged primates
Epitalon is a synthetic tetrapeptide derived from the amino acid composition of Epithalamin, a polypeptide extract derived from the bovine pineal gland [4]. Current preclinical evidence suggests that Epitalon may activate telomerase by upregulating human telomerase reverse transcriptase (hTERT), and in aged primates Epitalon has been studied in the context of regenerative and longevity endpoints [4]. This work is preclinical and concerns a pineal-derived peptide rather than cortisol itself; it is included here because pineal and adrenal timing systems are frequently discussed together in the rhythm literature.
Comparison of rhythm features across evidence types
| Feature | Human clinical evidence | Rodent / model evidence |
|---|---|---|
| Circadian rhythm of cortisol | Described; measured in controlled laboratory protocols [1] | Used to clarify mechanisms [2] |
| Ultradian pulsatility | Quantitative characterisation remains limited [2] | Mechanisms clarified in rodent studies and mathematical models [2] |
| Metabolic endpoint studied | Insulin resistance under sleep restriction [1] | Not specified in the evidence available |
| Hormones measured | Evening cortisol; daytime testosterone [1] | Not specified in the evidence available |
Sleep loss, shift work and rhythm disruption in adults
Contributors to sleep loss listed in the clinical literature include shift work, environmental disturbances, sleep and circadian disorders, and comorbid medical and mental health conditions [1]. Because sleep loss raises evening cortisol and lowers daytime testosterone, these populations are of interest for studies of timed cortisol release and insulin resistance [1]. The population named in that work is adults undergoing sleep restriction, both men and women [1].
Cortisol excess and secondary osteoporosis
Cushing syndrome is identified as a major cause of secondary osteoporosis, with postpartum fractures occasionally reported and fractures during pregnancy being exceptionally rare [3]. Adrenal CS cases that became apparent or worsened during pregnancy have been described [3]. The population here is patients with diagnosed CS, and the endpoint is fragility fracture, not rhythm parameters.
Pineal-derived peptides and cellular aging endpoints
Preclinical evidence suggests Epitalon may activate telomerase by upregulating hTERT, and aged primates have been studied in regenerative and longevity research [4]. This is animal and in vitro work; no human efficacy data are provided in the evidence available, and no claim about human outcomes is made here.
Where the evidence is animal-only or in vitro
Two areas in this body of evidence are explicitly non-human or non-clinical. Ultradian pulsatility mechanisms rest on rodent studies and mathematical models [2]. Epitalon's proposed telomerase activity rests on preclinical work, including aged primates [4]. The sleep-restriction and insulin-resistance protocol is a human study design [1], and the Cushing syndrome fracture literature concerns human patients [3].
If you are reading this for personal health reasons
The materials described on this page are sold for laboratory research use only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician. Nothing here is a recommendation, a dose, or a promise of any outcome.
Sources
- [1] Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07494084
- [2] Regulation of ultradian pulsatility and stress responses in the human hypothalamic-pituitary-adrenal axis. https://pubmed.ncbi.nlm.nih.gov/42710870/
- [3] Cushing syndrome manifested during pregnancy and diagnosed following a fragility fracture of the pelvis. https://pubmed.ncbi.nlm.nih.gov/42625849/
- [4] From Cellular Aging to Tissue Protection: Epitalon in Regenerative and Longevity Medicine. https://doi.org/10.20944/preprints202607.2123.v1